Oestrogen receptors revisited: Long-term follow up of over five thousand breast cancer patients

ANZ Journal of Surgery

Volumn 74, Issue 11, 2004, Pages 957-960

  Hähnel, Roland ^a   Spilsbury, Katrina ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast neoplasm; Oestrogen receptors; Progesterone receptors; Survival analysis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AUSTRALIA; BREAST TUMOR; CHEMISTRY; FEMALE; FOLLOW UP; HUMAN; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TIME;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TIME FACTORS; WESTERN AUSTRALIA;

EID: 16644364009     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-1433.2004.03215.x     Document Type: Article

References (18)

1. Jensen EF, Block GE, Smith S, Kyser K, DeSombre ER. Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monog. 1971; 34: 55-70.
2. Hahnel R, Woodings T, Vivian AB. Prognostic value of estrogen receptors in primary breast cancer. Cancer 1979; 44: 671-675 (Pubitemid 10220153)
3. Hahnel R. Estimation of estrogen receptors in the clinical laboratory. Pathol. Immunopathol. Res. 1986; 5: 54-72.
4. Hahnel R, Avenell MH, Hahnel E. Estrogen and progesterone receptor assays, by the EIA method (Abbott), of low-speed supernates of breast-cancer homogenates. Clin. Chem. 1989; 35: 2226-2227 (Pubitemid 20004699)
5. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol. 2003; 4: 251-254 (Pubitemid 36503323)
6. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients. 20-year follow-up before and after introduction of screening. Lancet 2003; 361: 1405-1410 (Pubitemid 36515039)
7. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J. Clin. Oncol. 2003; 21: 28-34.
8. Klemi PJ, Joensuu H, Toikkanen S et al. Aggressiveness of breast cancers found with and without screening. BMJ 1992; 304: 467-469
9. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J. Clin. Oncol. 2003; 21: 1973-1979 (Pubitemid 46606386)
10. Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database. Breast Cancer Res. Treat. 2002; 76: 27-36. (Pubitemid 35178626)
11. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J. Clin. Oncol. 2001; 19: 18-27. (Pubitemid 32063475)
12. Aaltomaa S, Lipponen P, Eskelinen M et al. Hormone receptors as prognostic factors in female breast cancer. Ann. Med. 1991; 23: 643-648
13. Nikolic-Vukosavljevic D, Kanjer K, Neskovic-Konstantinovic Z, Vukotic D. Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer. Int. J. Biol. Markers 2002; 17: 196-200. (Pubitemid 35370063)
14. Pichon MF, Broet P, Magdelenat H et al. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br. J. Cancer 1996; 73: 1545-1551 (Pubitemid 26235381)
15. Bernoux A, de Cremoux P, Laine-Bidron C, Martin EC, Asselain B, Magdelenat H. Estrogen receptor negative and progesterone receptor positive primary breast cancer. pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group. Breast Cancer Res. Treat. 1998; 49: 219-225 (Pubitemid 28416787)
16. Hupperets PS, Volovics L, Schouten LJ et al. The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer. Am. J. Clin. Oncol. 1997; 20: 546-551 (Pubitemid 27509875)
17. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas. correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J. Clin. Pathol. 2000; 53: 688-696 (Pubitemid 30692408)
18. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J. Clin. Oncol. 1998; 16: 2780-2795